IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $282,021 | -17.3% | 7,569 | -1.8% | 0.00% | 0.0% |
| Q3 2022 | $341,000 | -35.4% | 7,710 | -42.6% | 0.00% | 0.0% |
| Q2 2021 | $528,000 | +103.9% | 13,434 | +205.9% | 0.00% | – |
| Q2 2020 | $259,000 | -7.2% | 4,391 | -25.6% | 0.00% | – |
| Q1 2020 | $279,000 | -67.3% | 5,905 | -58.2% | 0.00% | -100.0% |
| Q4 2019 | $852,000 | -42.6% | 14,141 | -43.0% | 0.00% | -50.0% |
| Q3 2019 | $1,485,000 | -95.4% | 24,793 | -95.1% | 0.00% | -94.4% |
| Q2 2019 | $32,388,000 | -1.9% | 503,942 | +22.4% | 0.04% | +2.9% |
| Q1 2019 | $33,024,000 | +6226.4% | 411,874 | +4169.5% | 0.04% | +3400.0% |
| Q4 2018 | $522,000 | -19.7% | 9,647 | -23.5% | 0.00% | 0.0% |
| Q3 2018 | $650,000 | -10.6% | 12,606 | -27.7% | 0.00% | 0.0% |
| Q2 2018 | $727,000 | -5.3% | 17,441 | +0.2% | 0.00% | 0.0% |
| Q1 2018 | $768,000 | -16.2% | 17,414 | -4.5% | 0.00% | 0.0% |
| Q4 2017 | $917,000 | +1.3% | 18,227 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $905,000 | -93.9% | 17,857 | -95.6% | 0.00% | -95.7% |
| Q3 2016 | $14,934,000 | -65.5% | 407,582 | -78.1% | 0.02% | -69.7% |
| Q2 2016 | $43,278,000 | +171.7% | 1,858,239 | +372.6% | 0.08% | +162.1% |
| Q1 2016 | $15,926,000 | -58.1% | 393,235 | -36.0% | 0.03% | -56.7% |
| Q4 2015 | $38,030,000 | – | 614,086 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |